Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Neoplasms 2Prostatic Hyperplasia 1Prostatic Diseases 1

Interventions

padeliporfin 5Radiotherapy 2Pluvicto 2Nivolumab 2Androgen Antagonists 2palladium-bacteriopheophorbide 1ixabepilone 1gallium 68 PSMA-11 1enzalutamide 1darolutamide 1apalutamide 1Therapeutics 1Tamsulosin 1Surveys and Questionnaires 1Standard of Care 1Prostate-Specific Antigen 1Prednisone 1Oxygen 1Nitrous Oxide 1Microtubule-Associated Proteins 1Ipilimumab 1Docetaxel 1Cryotherapy 1Brachytherapy 1Biopsy, Needle 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Prostatic Diseases × Prostate-Specific Antigen × Clear all
NCT00853710 2025-11-20

Test Semiquantitative Prostate Specific Antigen (PSA)

Institut Curie

Phase NA Completed
94 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡